Summit Partners Public Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,555,408	Closed	-$12.5M	–	89
2024 Q2	$12.5M	Sell	1,555,408 -1,410,579	-48%	-$11.3M	0.48%	49
2024 Q1	$44M	Buy	+2,965,987	New	+$44M	1.51%	19